Literature DB >> 7640453

Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis.

S Mitsue1, M Hamanoue, G Tanabe, Y Ogura, S Yoshidome, T Aikou, T Nakamura.   

Abstract

Hepatocyte growth factor (HGF) is a potent mitogen for the maturation of hepatocytes in vitro which plays a role in liver regeneration in vivo. In addition, transforming growth factor-beta 1 (TGF-beta 1) is also a potent regulator of liver regeneration. In attempting to clarify the mechanisms related to liver regeneration after partial hepatectomy, we investigated the expression of HGF and TGF-beta 1 in rats with liver cirrhosis (LC). A rat model of LC was prepared using carbon tetrachloride (CCl4). The expression of HGF mRNA in both the LC and control groups showed a similar time-course with the highest expression seen at 18h after a 70% hepatectomy. The expression of TGF-beta 1 mRNA peaked at 18h after partial hepatectomy in the LC group and at 48h in the control group. The 5-bromo-2'-deoxyuridine (BrdU) labeling index for the LC group at 24, 48, and 72 h after partial hepatectomy was 9.2%, 5.9%, and 1.8%, while for the control group it was 7.0%, 11.7%, and 6.8%, respectively. The BrdU labeling index in the LC group was thus suppressed earlier than that in the control group. We therefore postulate that regeneration of the remnant liver in the presence of LC accelerates immediately after partial hepatectomy, but the extent of regeneration is insufficient because of an early cessation due to an early expression of TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640453     DOI: 10.1007/bf00311534

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

1.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

Review 2.  Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?

Authors:  R Pérez Tamayo
Journal:  Hepatology       Date:  1983 Jan-Feb       Impact factor: 17.425

3.  Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.

Authors:  B I Carr; I Hayashi; E L Branum; H L Moses
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

4.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.

Authors:  K Tashiro; M Hagiya; T Nishizawa; T Seki; M Shimonishi; S Shimizu; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

6.  Partial characterization of a hepatocyte growth factor from rat platelets.

Authors:  W E Russell; J A McGowan; N L Bucher
Journal:  J Cell Physiol       Date:  1984-05       Impact factor: 6.384

7.  Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids.

Authors:  K Matsumoto; H Tajima; H Okazaki; T Nakamura
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

8.  Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats.

Authors:  O Asami; I Ihara; N Shimidzu; S Shimizu; Y Tomita; A Ichihara; T Nakamura
Journal:  J Biochem       Date:  1991-01       Impact factor: 3.387

Review 9.  Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.

Authors:  K Matsumoto; T Nakamura
Journal:  Crit Rev Oncog       Date:  1992

10.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Authors:  D R Edwards; G Murphy; J J Reynolds; S E Whitham; A J Docherty; P Angel; J K Heath
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  4 in total

1.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy.

Authors:  Hironobu Makino; Hiroaki Shimizu; Hiroshi Ito; Fumio Kimura; Satoshi Ambiru; Akira Togawa; Masayuki Ohtsuka; Hiroyuki Yoshidome; Atsushi Kato; Hideyuki Yoshitomi; Shigeaki Sawada; Masaru Miyazaki
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

3.  Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Vladimir M Subbotin; Tadahiro Uemura; Michael Nalesnik; Anthony J Demetris; John J Fung; Thomas E Starzl
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

Review 4.  Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis.

Authors:  Nikolaos P Karidis; Ioanna Delladetsima; Stamatios Theocharis
Journal:  Gastroenterol Res Pract       Date:  2015-03-29       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.